Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Influenza and COVID-19: What does co-existence mean?

Research output: Contribution to journalReviewpeer-review

DOI

  1. Optimal timing of influenza vaccine during pregnancy: A systematic review and meta-analysis

    Research output: Contribution to journalReviewpeer-review

  2. The potential risks and impact of the start of the 2015-2016 influenza season in the WHO European Region: a rapid risk assessment

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Molecular Epidemiology and Evolutionary Trajectory of Emerging Echovirus 30, Europe

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Epidemiologi, klinik og behandling af SARS-CoV-2 infektion hos børn

    Research output: Contribution to journalReviewpeer-review

  3. First wave of COVID-19 hospital admissions in Denmark: a Nationwide population-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Risk of COVID-19 in health-care workers in Denmark: an observational cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Tawee Chotpitayasunondh
  • Thea Kølsen Fischer
  • Jean-Michel Heraud
  • Aeron C Hurt
  • Arnold S Monto
  • Albert Osterhaus
  • Yuelong Shu
  • John S Tam
View graph of relations

The COVID-19 pandemic caused by the novel coronavirus SARS-CoV-2 continues to have a major impact on healthcare and social systems throughout the world. As the clinical and epidemiological features of COVID-19 have many parallels with influenza, it is important to ensure optimal management of both respiratory diseases as we anticipate their continued co-circulation. In particular, there is a need to ensure that effective surveillance and diagnostic capacities are in place to monitor these and other respiratory viruses, as this will underpin decisions on the appropriate clinical management of the respective diseases. As such, we propose a series of key recommendations for stakeholders, public health authorities, primary care physicians and surveillance bodies that will help mitigate the combined risks of concurrent influenza epidemics and the COVID-19 pandemic. We advocate the judicious use of influenza vaccines and antivirals, particularly among groups at high risk of complications, with healthcare workers also considered a priority for vaccination. It is likely that the increased use of emerging technologies such as telemedicine and contact tracing will permanently change our approach to managing infectious disease. The use of these technologies, alongside existing pharmaceutical strategies, will ensure that we achieve a holistic approach to the global public health measures needed to deal with the combined threat of influenza and COVID-19. Ensuring that this approach is optimal will be key as we move from a reactive pandemic response towards preparing for the long-term management of the remarkable clinical burden associated with these respiratory pathogens.

Original languageEnglish
JournalInfluenza and other Respiratory Viruses
Volume15
Issue number3
Pages (from-to)407-412
Number of pages6
ISSN1750-2640
DOIs
Publication statusPublished - May 2021

    Research areas

  • antivirals, clinical management, COVID-19, influenza, SARS-CoV-2, surveillance

ID: 61339266